Sep 17 |
Ascendis Soars on Encouraging Data From Dwarfism Drug Study
|
Sep 10 |
Xencor Stock Gains 23% on Encouraging Pipeline Advancements
|
Sep 10 |
Summit Hits Record High on Lung Cancer Drug Topping Merck's Keytruda
|
Sep 5 |
BioMarin Posts '27 Biz View, Outlines Growth Plans for Next 10 Years
|
Aug 30 |
JNJ Seeks First FDA Nod for Autoimmune Disease Drug Nipocalimab
|
Aug 30 |
Merck Scraps Two Late-Stage Keytruda Studies on Disappointing Data
|
Aug 29 |
Bull Of The Day: Bioventus (BVS)
|
Aug 29 |
Bioventus and Pool have been highlighted as Zacks Bull and Bear of the Day
|
Aug 28 |
Pfizer Follows Lilly's Example, Unveils DTC Service for Selling Drugs
|
Aug 28 |
Soleno Stock Up as FDA Accepts PWS Drug NDA Under Priority Review
|